Company Filing History:
Years Active: 1990-2004
Title: Shuet-Hing Lee Chiu: Innovator in Tachykinin Receptor Antagonists
Introduction
Shuet-Hing Lee Chiu is a notable inventor based in Westfield, NJ (US). He has made significant contributions to the field of pharmacology, particularly in the development of tachykinin receptor antagonists. With a total of 4 patents to his name, his work has implications for the treatment of various disorders.
Latest Patents
One of his latest patents is focused on mammalian metabolites of a tachykinin receptor antagonist. This invention pertains to the compound 2-(R)-(1-(R)-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(S)-(4-fluoro)-phenyl-4-(3-(5-oxo-1H,4H-1,2,4-triazolo)methylmorpholine. This compound is particularly useful in the prevention and treatment of disorders such as emesis and psychiatric conditions, including depression and anxiety.
Another significant patent involves 7-substituted 4-aza cholanic acid derivatives and their applications. These innovations reflect his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Shuet-Hing Lee Chiu is currently associated with Merck & Company, Inc., a leading global healthcare company. His work at Merck has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Throughout his career, he has collaborated with esteemed colleagues, including Josephine R Carlin and Donald W Graham. These partnerships have fostered a collaborative environment that enhances innovation and research.
Conclusion
Shuet-Hing Lee Chiu is a distinguished inventor whose work in tachykinin receptor antagonists has the potential to transform treatment options for various disorders. His contributions to the field of pharmacology are noteworthy and continue to impact the healthcare landscape.